Glenmark Life Sciences Limited (GLS.BO)
INR 1021.7
(-0.42%)
INR 1021.7
(-0.42%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 38.43 INR | 0.84% |
| 2022 | 38.11 INR | 6.96% |
| 2021 | 35.63 INR | 9.26% |
| 2020 | 32.61 INR | 12.29% |
| 2019 | 29.04 INR | 21.56% |
| 2018 | 23.89 INR | 59380.4% |
| 2017 | -0.04 INR | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | 7.78 INR | -14.51% |
| 2024 Q1 | 9.10 INR | 13.89% |
| 2023 Q1 | 11.05 INR | -7.45% |
| 2023 FY | - INR | 0.84% |
| 2023 Q3 | 9.69 INR | 0.0% |
| 2023 Q2 | 9.69 INR | -12.31% |
| 2023 Q4 | 7.99 INR | -17.54% |
| 2022 Q1 | 8.87 INR | 9.91% |
| 2022 FY | - INR | 6.96% |
| 2022 Q4 | 11.94 INR | 39.32% |
| 2022 Q3 | 8.57 INR | -1.72% |
| 2022 Q2 | 8.72 INR | -1.69% |
| 2021 Q1 | 8.24 INR | -15.14% |
| 2021 Q2 | 9.83 INR | 19.3% |
| 2021 Q3 | 8.65 INR | -12.0% |
| 2021 Q4 | 8.07 INR | -6.71% |
| 2021 FY | - INR | 9.26% |
| 2020 FY | - INR | 12.29% |
| 2020 Q4 | 9.71 INR | 27.43% |
| 2020 Q3 | 7.62 INR | 28.93% |
| 2020 Q2 | 5.91 INR | -21.41% |
| 2020 Q1 | 7.52 INR | 0.0% |
| 2019 FY | - INR | 21.56% |
| 2018 FY | - INR | 59380.4% |
| 2017 FY | - INR | 0.0% |